source
- #ASCO26: Lilly's plenaries; Incyte's frontline data in lymphomaTwo plenaries related to Lilly: Researchers detailed findings from an investigator-sponsored trial using Lilly’s CDK4/6 inhibitor Verzenio in a rare cancer called dedifferentiated liposarcoma, show…Endpoints · 2mo ago↗ source
- As FDA misses deadline on electric shock ban, disability advocates speak outThe FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual disabilities.STAT · 2mo ago↗ source
- STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues UnitedWe've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.STAT · 2mo ago↗ source